{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:38:25Z","timestamp":1776440305414,"version":"3.51.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Innovation Fund and the Innovation Committee of the Federal Joint Committee","award":["01NVF16028"],"award-info":[{"award-number":["01NVF16028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Both diagnosis and treatment of neurological emergencies require neurological expertise and are time-sensitive. The lack of fast neurological expertise in regions with underserved infrastructure poses a major barrier for state-of-the-art care of patients with acute neurological diseases and leads to disparity in provision of health care. The main purpose of ANNOTeM (acute neurological care in North East Germany with telemedicine support) is to establish effective and sustainable support structures for evidence based treatments for stroke and other neurological emergencies and to improve outcome for acute neurological diseases in these rural regions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A \u201chub-and-spoke\u201d network structure was implemented connecting three academic neurological centres (\u201chubs\u201d) and rural hospitals (\u201cspokes\u201d) caring for neurological emergencies. The network structure includes (1) the establishment of a 24\/7 telemedicine consultation service, (2) the implementation of standardized operating procedures (SOPs) in the network hospitals, (3) a multiprofessional training scheme, and (4) a quality management program. Data from three major health insurance companies as well as data from the quality management program are being collected and evaluated. Primary outcome is the composite of first time of receiving paid outpatient nursing care, first time of receiving care in a nursing home, or death within 90\u2009days after hospital admission.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Beyond stroke only few studies have assessed the effects of telemedically supported networks on diagnosis and outcome of neurological emergencies. ANNOTeM will provide information whether this approach leads to improved outcome. In addition, a health economic analysis will be performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study registration<\/jats:title>\n                <jats:p>German Clinical Trials Register DRKS00013067, date of registration: November 16 th, 2017, URL: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.drks.de\/DRKS00013068\">http:\/\/www.drks.de\/DRKS00013068<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-020-05576-w","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T09:06:44Z","timestamp":1597655204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acute neurological care in north-east Germany with telemedicine support (ANNOTeM): protocol of a multi-center, controlled, open-label, two-arm intervention study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1666-6021","authenticated-orcid":false,"given":"J. E.","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Angermaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Bollweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Erdur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fl\u00f6el","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gorski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. I.","family":"Kandil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kinze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kleinsteuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Schmehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Theen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Endres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. J.","family":"Audebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the ANNOTeM-consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"5576_CR1","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","volume":"384","author":"J Emberson","year":"2014","unstructured":"Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384:1929\u201335.","journal-title":"Lancet"},{"key":"5576_CR2","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Davalos A, Majoie CB, van der Lugt A, de Miquel MA, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723\u201331.","journal-title":"Lancet"},{"key":"5576_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ncl.2011.09.005","volume":"30","author":"B Foreman","year":"2012","unstructured":"Foreman B, Hirsch LJ. Epilepsy emergencies: diagnosis and management. Neurol Clin. 2012;30:11\u201341 vii.","journal-title":"Neurol Clin"},{"key":"5576_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12879-016-1711-z","volume":"16","author":"J Bodilsen","year":"2016","unstructured":"Bodilsen J, Dalager-Pedersen M, Schonheyder HC, Nielsen H. Time to antibiotic therapy and outcome in bacterial meningitis: a Danish population-based cohort study. BMC Infect Dis. 2016;16:392.","journal-title":"BMC Infect Dis"},{"key":"5576_CR5","doi-asserted-by":"publisher","first-page":"84S","DOI":"10.1177\/2192568217703387","volume":"7","author":"MG Fehlings","year":"2017","unstructured":"Fehlings MG, Tetreault LA, Wilson JR, Kwon BK, Burns AS, Martin AR, Hawryluk G, Harrop JS. A clinical practice guideline for the Management of Acute Spinal Cord Injury: introduction, rationale, and scope. Global Spine J. 2017;7:84S\u201394S.","journal-title":"Global Spine J"},{"key":"5576_CR6","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","volume":"386","author":"CJ Murray","year":"2015","unstructured":"DALYs GBD, Collaborators H, Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, Aboyans V, Abraham JP, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015;386:2145\u201391.","journal-title":"Lancet"},{"key":"5576_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1212\/WNL.0000000000008708","volume":"94","author":"JM Hatcher-Martin","year":"2020","unstructured":"Hatcher-Martin JM, Adams JL, Anderson ER, Bove R, Burrus TM, Chehrenama M, Dolan O'Brien M, Eliashiv DS, Erten-Lyons D, Giesser BS, et al. Telemedicine in neurology: telemedicine work Group of the American Academy of neurology update. Neurology. 2020;94:30\u20138.","journal-title":"Neurology"},{"key":"5576_CR8","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1161\/STROKEAHA.109.192360","volume":"40","author":"LH Schwamm","year":"2009","unstructured":"Schwamm LH, Holloway RG, Amarenco P, Audebert HJ, Bakas T, Chumbler NR, Handschu R, Jauch EC, Knight WA, Levine SR, et al. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association\/American Stroke Association. Stroke. 2009;40:2616\u201334.","journal-title":"Stroke"},{"key":"5576_CR9","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1161\/01.STR.0000102043.70312.E9","volume":"34","author":"R Handschu","year":"2003","unstructured":"Handschu R, Littmann R, Reulbach U, Gaul C, Heckmann JG, Neundorfer B, Scibor M. Telemedicine in emergency evaluation of acute stroke: interrater agreement in remote video examination with a novel multimedia system. Stroke. 2003;34:2842\u20136.","journal-title":"Stroke"},{"key":"5576_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/01.STR.0000153015.57892.66","volume":"36","author":"HJ Audebert","year":"2005","unstructured":"Audebert HJ, Kukla C, Clarmann von Claranau S, Kuhn J, Vatankhah B, Schenkel J, Ickenstein GW, Haberl RL, Horn M. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic pilot project for integrative stroke care (TEMPiS) in Bavaria. Stroke. 2005;36:287\u201391.","journal-title":"Stroke"},{"key":"5576_CR11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S1474-4422(08)70171-6","volume":"7","author":"BC Meyer","year":"2008","unstructured":"Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, Thomas RG, Lyden PD. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol. 2008;7:787\u201395.","journal-title":"Lancet Neurol"},{"key":"5576_CR12","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1212\/01.wnl.0000269671.08423.14","volume":"69","author":"S Schwab","year":"2007","unstructured":"Schwab S, Vatankhah B, Kukla C, Hauchwitz M, Bogdahn U, Furst A, Audebert HJ, Horn M, Group TE. Long-term outcome after thrombolysis in telemedical stroke care. Neurology. 2007;69:898\u2013903.","journal-title":"Neurology"},{"key":"5576_CR13","first-page":"405","volume":"75","author":"J Schenkel","year":"2013","unstructured":"Schenkel J, Reitmeir P, Von Reden S, Holle R, Boy S, Haberl R, Audebert H. Cost analysis of telemedical treatment of stroke. Gesundheitswesen. 2013;75:405\u201312.","journal-title":"Gesundheitswesen"},{"key":"5576_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00115-018-0633-y","volume":"90","author":"DG Nabavi","year":"2019","unstructured":"Nabavi DG, Koennecke HC, Ossenbrink M, Grau A, Busse O, die Stroke Unit K, den Zertifizierungsausschuss der DSG, den Vorstand der DSG, den Zertifizierungsausschuss der DSG. Certification criteria for stroke units in Germany : update 2018. Nervenarzt. 2019;90:335\u201342.","journal-title":"Nervenarzt"},{"key":"5576_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13049-016-0250-3","volume":"24","author":"M Braun","year":"2016","unstructured":"Braun M, Schmidt WU, Mockel M, Romer M, Ploner CJ, Lindner T. Coma of unknown origin in the emergency department: implementation of an in-house management routine. Scand J Trauma Resusc Emerg Med. 2016;24:61.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"5576_CR16","unstructured":"Standardisierte optimierte Prozeduren (SOP) in der Schlaganfallbehandlung [http:\/\/www.tempis.de\/index.php\/sop-druckversion\/finish\/1-sop\/535-tempis-sop-2015-druckversionpdf.html?25a99fb6f5cd3a21c61698db179a5bfa=2001ccda4ae3c6e221909eee46995a94]."},{"key":"5576_CR17","volume-title":"Gutachten 2014 des Sachverst\u00e4ndigenrates zur Begutachtung der Entwicklung im Gesundheitswesen. Bedarfsgerechte Versorgung \u2013 Perspektiven f\u00fcr l\u00e4ndliche Regionen und ausgew\u00e4hlte Leistungsbereiche","author":"Sachverst\u00e4ndigenrat zur Begutachtung der Entwicklung im Gesundheitswesen (2014)","year":"2014","unstructured":"Sachverst\u00e4ndigenrat zur Begutachtung der Entwicklung im Gesundheitswesen (2014) Gutachten 2014 des Sachverst\u00e4ndigenrates zur Begutachtung der Entwicklung im Gesundheitswesen. Bedarfsgerechte Versorgung \u2013 Perspektiven f\u00fcr l\u00e4ndliche Regionen und ausgew\u00e4hlte Leistungsbereiche 2014."},{"key":"5576_CR18","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1161\/STROKEAHA.108.529255","volume":"40","author":"HJ Audebert","year":"2009","unstructured":"Audebert HJ, Schultes K, Tietz V, Heuschmann PU, Bogdahn U, Haberl RL, Schenkel J. Telemedical project for integrative stroke C: long-term effects of specialized stroke care with telemedicine support in community hospitals on behalf of the Telemedical project for integrative stroke care (TEMPiS). Stroke. 2009;40:902\u20138.","journal-title":"Stroke"},{"key":"5576_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200\u20137.","journal-title":"Ann Intern Med"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05576-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-020-05576-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05576-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:17:16Z","timestamp":1629159436000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-020-05576-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5576"],"URL":"https:\/\/doi.org\/10.1186\/s12913-020-05576-w","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"22 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ANNOTeM study has been approved by the ethics committee (Charit\u00e9 Campus Mitte; Berlin\/Germany; no. EA1\/078\/10 and subsequently by the responsible ethics committees in Brandenburg (AS 90(bB)\/2018) and Mecklenburg-Western Pomerania (BB 057\/18)) and the Data Protection Department of the Charit\u00e9. Any changes to the study protocol, must be approved by the Ethics Committee before implementation. According to the positive votes of the ethics committees, informed consent for participation in this study is not necessary.Within ANNOTeM, the analysis of outcomes is carried out on the basis of health insurance data. A formal approval of the participating hospitals or individual patients for using data of the health insurances is not necessary. The evaluation of the data is based exclusively on anonymised data, which are therefore no longer subject to the General Data Protection Rights (GDPR). The release of the data of the health insurance companies for this purpose was approved by the supervisory authority of the health insurance companies. It is registered at German Clinical Trials Register (DRKS00013067, date of registration: November 16th, 2017, URL: ). The study will be conducted in accordance with the Declaration of Helsinki in its current version, the guidelines of the International Conference on Harmonization of Good Clinical Practice (ICH-GCP), and the applicable German laws.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"AA, KB, HE, SE, CG, FIK, SK, KK, IS, ST, and JEW report no disclosures.ME reports grants from Bayer and fees paid to the Charite from Amgen, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daichi Sankyo, Novartis, Pfizer, Sanofi, all outside of this work.AF has received consulting fees from Bayer, Roche, Novartis, Biogen Idec, and NovagoTherapeutics, and honoraria for oral presentations from Novartis, B\u00f6hringer-Ingelheim, Eli-Lilly and Company, Biogen Idec, Paul-Martini-Stiftung, and Daiichi-Sankyo.TK reports having contributed to an advisory board of CoLucid and a research project funded by Amgen, for which the Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin received an unrestricted compensation. He further reports having received honoraria from Lilly, Newsenselab, and Total for providing methodological advice, from Novartis and from Daiichi Sankyo for providing a lecture on neuroepidemiology and research methods, and from the BMJ for editorial services. HJA reports speaker fees and consultancy honoraria received during the conduct of the study from Bayer Vital, Boehringer Ingelheim Pharma, Bristol-Myers-Squibb, Novo Nordisk and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"755"}}